
|Videos|March 3, 2023
A Medical Oncologist’s Recommended Interventions For CV Risk Mitigation
Urologist David Morris, MD, FACS, shares his perspective on communicating cardiovascular risk to patients starting androgen deprivation therapy.
Advertisement
Episodes in this series

January 2023 AbbVie Inc. Company Confidential
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Kristen Scarpato, MD, on combination strategies in BCG-naïve NMIBC
2
Trial to compare 225Ac-PSMA-617 vs 177Lu-PSMA-617 for oligorecurrent prostate cancer
3
Farah Rahman, MD, on monitoring resident wellness using biofeedback
4
John Sfakianos, MD, on dual immune checkpoint inhibition in NMIBC
5













